Literature DB >> 16355332

Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes.

Elie F Berbari1, Douglas R Osmon, Mary C T Duffy, R N William Harmssen, Jayawant N Mandrekar, Arlen D Hanssen, James M Steckelberg.   

Abstract

BACKGROUND: Prosthetic joint infection in patients with rheumatoid arthritis is a serious complication of total joint arthroplasty. Little information is available on the outcome of medical and surgical treatments of prosthetic joint infection in patients with rheumatoid arthritis.
METHODS: We conducted a retrospective analysis of all patients with rheumatoid arthritis and a total hip or total knee arthroplasty infection evaluated at Mayo Clinic (Rochester, MN) between 1 January 1969 and 31 December 1995.
RESULTS: A total of 200 first episodes of prosthetic joint infection in 160 patients with rheumatoid arthritis were diagnosed during the study period. Thirty-seven percent of prosthetic joint infection episodes were due to Staphylococcus aureus. Of these episodes, 23% and 19% were treated with debridement and retention of components and 2-stage exchange, respectively. The type of surgical procedure was the only analyzed clinical variable that was associated with treatment failure (P < .001). Rates of 5-year survival free of treatment failure for patients with prosthetic joint infection episodes treated with debridement and retention of components, 2-stage exchange, and resection arthroplasty were 32% (95% confidence interval [CI], 21%-49%), 79% (95% CI, 66%-93%), and 61% (95% CI, 49%-74%), respectively.
CONCLUSIONS: S. aureus is the most common pathogen among patients with rheumatoid arthritis with prosthetic joint infection. Two-stage exchange was used in only 19% of the prosthetic joint infection episodes among patients with rheumatoid arthritis during the study period, but it was associated with the best outcome. The variable most strongly associated with the outcome was the type of surgical procedure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16355332     DOI: 10.1086/498507

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection.

Authors:  Davud Malekzadeh; Douglas R Osmon; Brian D Lahr; Arlen D Hanssen; Elie F Berbari
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention.

Authors:  O C El Helou; E F Berbari; B D Lahr; J E Eckel-Passow; R R Razonable; I G Sia; A Virk; R C Walker; J M Steckelberg; W R Wilson; A D Hanssen; D R Osmon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-27       Impact factor: 3.267

3.  Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers.

Authors:  Rashid Tikhilov; Svetlana Bozhkova; Alexey Denisov; Dmitry Labutin; Igor Shubnyakov; Vadim Razorenov; Vasilii Artyukh; Olga Klitsenko
Journal:  Int Orthop       Date:  2015-12-19       Impact factor: 3.075

4.  [The treatment of periprosthetic infections].

Authors:  C H Lohmann; M Fürst; O Niggemeyer; W Rüther
Journal:  Z Rheumatol       Date:  2007-02       Impact factor: 1.372

5.  Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective?

Authors:  Trisha N Peel; Allen C Cheng; Kirsty L Buising; Peter F M Choong
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

Review 6.  [Endoprosthesis infections of the shoulder: diagnosis and therapy algorithm].

Authors:  R Hudek; F Gohlke
Journal:  Orthopade       Date:  2013-07       Impact factor: 1.087

7.  Revision total knee arthroplasty for aseptic and septic causes in patients with rheumatoid arthritis.

Authors:  Ryan M Garcia; Brian T Hardy; Matthew J Kraay; Victor M Goldberg
Journal:  Clin Orthop Relat Res       Date:  2010-01       Impact factor: 4.176

8.  Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections.

Authors:  Y Maaloum; A Meybeck; D Olive; N Boussekey; P-Y Delannoy; A Chiche; H Georges; E Beltrand; E Senneville; T d'Escrivan; O Leroy
Journal:  Infection       Date:  2012-10-25       Impact factor: 3.553

9.  Cemented polyethylene cups in patients younger than 40 years.

Authors:  Daniël C J de Kam; Jean W M Gardeniers; Jan C M Hendriks; René P H Veth; B Willem Schreurs
Journal:  Clin Orthop Relat Res       Date:  2009-04-16       Impact factor: 4.176

Review 10.  Clinical practice. Infection associated with prosthetic joints.

Authors:  Jose L Del Pozo; Robin Patel
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.